PALISADE CAPITAL MANAGEMENT, LP - CASTLE BIOSCIENCES INC ownership

CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 130 filers reported holding CASTLE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.7%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of CASTLE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$10,172,188
+23.1%
602,261
+0.0%
0.28%
+29.1%
Q2 2023$8,262,239
-37.0%
602,204
+4.4%
0.22%
-37.9%
Q1 2023$13,109,849
+1.1%
577,018
+4.7%
0.35%
+1.7%
Q4 2022$12,972,776
-14.2%
551,095
-5.0%
0.35%
-18.9%
Q3 2022$15,125,000
+19.0%
579,944
+0.2%
0.43%
+24.7%
Q2 2022$12,708,000
-30.8%
578,933
+41.5%
0.34%
-18.5%
Q1 2022$18,358,000
+21.5%
409,232
+16.1%
0.42%
+37.9%
Q4 2021$15,109,000352,4410.31%
Other shareholders
CASTLE BIOSCIENCES INC shareholders Q2 2023
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 33,626$567,94377.21%
Millrace Asset Group, Inc. 77,315$1,3061.61%
Granahan Investment Management 2,487,673$42,016,7971.50%
Parkman Healthcare Partners LLC 224,592$3,793,3590.70%
PERKINS CAPITAL MANAGEMENT INC 29,160$4930.49%
Capital Impact Advisors, LLC 16,554$279,5970.47%
Soleus Capital Management, L.P. 283,500$4,788,3150.44%
Portolan Capital Management 253,028$4,273,6430.40%
Numerai GP LLC 68,163$1,151,2730.38%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 946,620$15,988,4120.35%
View complete list of CASTLE BIOSCIENCES INC shareholders